All In Biotech

Drug Trial Radar · NCT07691242

Multiple Ascending Dose Study of DW4421

A Phase 1 Clinical Trial to Evaluate the Safety, the Pharmacokinetics and Pharmacodynamics After Multiple Administration of DW4421 in Healthy Adult Volunteers

Last checked: Nov 20, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

56

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Dec 2026

Study completion Feb 2027

Sponsor

Sponsor type
Industry
First posted
Jul 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Multiple Ascending Dose of DW4421, phase I

Conditions

  • Healthy Adult Volunteers

Interventions

  • DW4421S-T0Drug

    DW4421 5mg

  • DW4421S-T2Drug

    DW4421 15mg

  • DW4421S-T1Drug

    DW4421 20mg

  • DW4421S-T3Drug

    DW4421 30mg

  • DW4421SDrug

    DW4421 40mg

  • DW4421-3Drug

    Zastaprazan 20mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUCτ,ss, Area under the drug concentration-time curve of DW4421 following multiple oral administrationTime frame: Day 7
  2. Cmax of DW4421 following multiple oral administrationTime frame: Day 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.